prospective observational study to assess efficacy and safety of nivolumab in patients with recurrent non-small cell lung cancer
Latest Information Update: 20 Jul 2016
At a glance
- Drugs Nivolumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 20 Jul 2016 New trial record